Furthermore, the activation of EGCs is attended by a vast release of IL-6 and other inflammatory intermediates that could result in acute respiratory discomfort, as observed in the SARS-CoV-2 induced cytokine storms experienced by COVID-19 patients [86]. Here, IL6 is linked to COVID-19.